Pons Pharma, Inc.
Commercializing rapidly disintegrating medicines for chronically ill children who can't swallow conventional hard pills needed to treat their illness
Specialized pharmaceutical company focused on achieving dramatically
higher adherence to the drug regimens needed by chronically ill pediatric
patients. Seeking capital to fund the commercialization stages of first products